🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1996-05
Trial ID
NCT00008203
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
The purpose of this study is to test the hypothesis that a pre-infusion pre...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2004-01
Trial ID
NCT00167180
Treatments Being Tested
The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-07
Trial ID
NCT00146562
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
RATIONALE: Bone marrow transplantation may be able to replace immune cells ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2000-02
Trial ID
NCT00005988
This phase I trial studies the side effects and best dose of ADH-1 when giv...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2013-04-09
Trial ID
NCT01825603
Treatments Being Tested
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Status
Completed
Location
Cancer Research Campaign Trials Unit-Birmingham (CRCTU)
Start Date
1993-06
Trial ID
NCT00002582
This non-randomised open-label prospective pilot study evaluates the safety...
Status
Unknown
Location
Kirill Zykov
Start Date
2018-06-20
Trial ID
NCT04278040
Treatments Being Tested